InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Altarac David, Directeur Médical. Director active across 1 company, notably Entasis Therapeutics Holdings Inc.. Cumulatively, 4 disclosures have been logged. History available since 19 October 2021. The latest transaction was filed on 7 July 2022 (U). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
David Altarac is the Chief Medical Officer of Entasis Therapeutics Holdings Inc. He oversees the clinical and medical aspects of the company's research and development projects. His medical expertise is essential to ensure the quality and efficacy of the treatments developed.